Is IBO (IBO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 12.6% / 30% | 2.8% / 30% | 0.3% / 30% | N/A | ✓ HALAL |
| DJIM | 12.6% / 33% | 2.8% / 33% | 0.3% / 33% | N/A | ✓ HALAL |
| MSCI | 43.8% / 33% | 9.9% / 33% | 0.9% / 33% | N/A | ✗ NOT HALAL |
| S&P | 12.6% / 33% | 2.8% / 33% | 0.3% / 33% | N/A | ✓ HALAL |
| FTSE | 43.8% / 33% | 9.9% / 33% | 0.9% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | -16542.9% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -104.2% | |
| Return on Assets (ROA) | -14.2% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$2M |
| Free Cash Flow | -$2M |
| Current Ratio | 0.4 |
| Total Assets | $17M |
Price & Trading
| Last Close | $0.56 |
| 50-Day MA | $0.50 |
| 200-Day MA | $0.56 |
| Avg Volume | 4.5M |
|
52-Week Range
$0.36
| |
About IBO (IBO)
Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer healthcare, and wellness products in the United States. The company provides Linebacker, a platform of small molecule electrophilically enhanced polyphenol compounds with application in oncology, inflammatory disorders, and neurology; and Laetose technology that is derived from a unique combination of sugar and inositol, which can inhibit the inflammatory and metabolic response of sugar alone. It also develops functional fragrance formulation, a suite of functional fragrances containing specialized botanical ingredients with application as an antimicrobial, and as an additive in insect repellents, detergents, lotions, shampoo, fabrics, and other substances. In addition, the company develops Equivir/Equivir G technology, a novel blend of polyphenols, which have demonstrated antiviral effects for use as health supplements and medications. Further, it is developing 3F (functional fragrance formulation), a formulation of botanical ingredients. Impact BioMedical Inc. was incorporated in 2018 and is based in Houston, Texas. Impact BioMedical Inc. operates as a subsidiary of DSS BioHealth Security, Inc
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is IBO (IBO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), IBO is Halal. The company passes all financial ratio thresholds for debt, cash, receivables, and impermissible income. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is IBO's debt ratio?
IBO's debt ratio is 12.6% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 43.8%.
What are IBO's key financial metrics?
IBO has a market capitalization of $62M, and revenue of $32,000. Return on equity stands at -104.2%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.